Summary
Intel Corporation (INTC) has entered into a significant direct funding agreement with the U.S. Department of Commerce (DOC) under the CHIPS Act, securing up to $7.8 billion in direct funding and $65 million for workforce development. This funding is designated for the construction, modernization, and operation of twelve microchip fabrication and advanced packaging facilities across Arizona, New Mexico, Ohio, and Oregon, supporting Intel's strategic expansion and commitment to domestic semiconductor production. The agreement, however, comes with substantial conditions and restrictions. Disbursements are tied to achieving specific milestones, including capital expenditures, facility completion, and production targets. Intel is also subject to various covenants, such as restrictions on dividends, share repurchases, expansion in certain foreign countries, and specific foreign entity equipment usage. Furthermore, the company must commit to significant U.S.-based R&D spending and faces limitations on 'change of control' transactions and dispositions of the funded projects. Intel may also be required to share a percentage of project-level excess free cash flow with the DOC.
Key Highlights
- 1Intel secures up to $7.8 billion in direct funding and $65 million for workforce development from the U.S. Department of Commerce under the CHIPS Act.
- 2Funding is allocated for twelve microchip fabrication and advanced packaging facilities across Arizona, New Mexico, Ohio, and Oregon.
- 3Disbursements are milestone-based, contingent on achieving capital expenditure, facility completion, production, and R&D targets.
- 4The agreement imposes significant restrictions on Intel, including limitations on dividends, share repurchases, and expansion in certain foreign countries.
- 5Intel must spend at least $35 billion on U.S. R&D cumulatively from 2024 through 2028.
- 6The agreement includes strict 'change of control' provisions and limitations on the disposition of funded projects.
- 7Intel may be required to share a percentage of a project's excess unlevered free cash flow with the DOC, capped at 75% of the received award for that project.